Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Uncollected Medical Fees - Why Don't Patients Pay?
August 29, 2005
- REGULATORY NEWS IN BRIEF
August 29, 2005
- Nippon Chemiphar Announces New 3-Year Management Plan
August 22, 2005
- More than 400 Medical Institutions Issue GE Name Prescriptions
August 22, 2005
- MediciNova Starts PII Trial of Ibudilast for MS
August 22, 2005
- Burgeoning Clinical Trial Business in China
August 22, 2005
- 1st Qtr Business Results
August 22, 2005
- NEW PRODUCTS
August 22, 2005
- Associations Petition for Rapid Increase in Review Staff
August 22, 2005
- Olympus, Terumo to Develop New Medical Devices Based on Capital Alliance
August 22, 2005
- SELF-MEDICATION
August 22, 2005
- Retirees Drove Growth in Medical Expenditure in FY2004: Survey
August 22, 2005
- Council Calls for More Screening of Hepatitis C
August 22, 2005
- Record Number of High-cost Medical Bills in FY2004: Kenporen
August 22, 2005
- REGULATORY NEWS IN BRIEF
August 22, 2005
- Piecework System Encourages Unnecessary Healthcare: White Paper
August 22, 2005
- Sales of Olmetec Rising Steadily Since May: Sankyo
August 22, 2005
- AJHA Calls For Increases in Medical Fees
August 22, 2005
- MPC Takes 1st Step to Become Global Drug Discovery Company with Argatroban in Germany: Mr Komine
August 22, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 22, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…